Trials / Unknown
UnknownNCT03046173
Concentrated Growth Factors Applied in Maxillary Sinus Floor Elevation Via a Lateral Window Approach
Osteogenic Effects of Concentrated Growth Factors Applied in Maxillary Sinus Floor Elevation Via a Lateral Window Approach With Simultaneous Implant Placement: a Single-center Randomized Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Deyang Stomatological Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the effects of concentrated growth factors applied in maxillary sinus floor elevation via a lateral window approach with simultaneous implant placement on repair of bone defects and new bone formation.
Detailed description
Maxillary sinus floor elevation via a lateral window approach is the most effective method of overcoming the shortage of bone mass deficiency in atrophic maxillary posterior region. Bone transplantation is considered to be a prerequisite for the success of maxillary sinus floor elevation. Platelet-rich plasma and platelet-rich fibrin have been used to accelerate bone formation, regeneration, and repair. However, few in-depth studies are reported on the effects of concentrated growth factors on new bone formation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | concentrated growth factors | These patients were randomly assigned to receive concentrated growth factors, hydroxyapatite and autogenous bone at bone defect sites in the experimental group. |
| OTHER | hydroxyapatite and autogenous bone | These patients were randomly assigned to receive hydroxyapatite and autogenous bone at bone defect sites in the control group. |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2016-01-01
- Completion
- 2017-05-01
- First posted
- 2017-02-08
- Last updated
- 2017-02-08
Source: ClinicalTrials.gov record NCT03046173. Inclusion in this directory is not an endorsement.